The Glen Research concept was based on our perception that the research community required a supply of novel reagents which, at first glance, may have seemed of little commercial value to the larger suppliers. We saw these esoteric products as the potential vehicles for the development of novel strategies for use in diagnostics, sequencing, and therapeutics. At the same time, we foresaw a need to provide products for routine oligonucleotide synthesis backed with quality specifications, analytical techniques and certification at the highest level.
The initial Glen Research offering in 1987 contained a complete set of reagents for DNA synthesis for cyanoethyl (CE) phosphoramidite chemistry which then was rapidly gaining acceptance. Modest though this range may have been, it was of major significance due to the Certificates of Analysis which accompanied every product. The analytical techniques and quality criteria used for the evaluation and acceptance of these reagents were to become an industry standard many years later.
This rather routine beginning was soon followed by the products which have become the Glen Research specialty: the largest selection of minor base phosphoramidites available and a potentially bewildering variety of reagents for oligonucleotide modification. To aid researchers in deciphering this array of products and to prompt them as to potential uses, the Glen Research Report was launched. Now published semi-annually as The Glen Report, this unique, valuable and respected newsletter has introduced an astonishing array of novel reagents while elucidating some complex chemical strategies and techniques. Today, Glen Research still offers far and away the widest selection of minor base phosphoramidites, modifiers and reagents for labelling oligonucleotides during the synthesis.
In 1989, Glen Research expanded into the delicate art of RNA synthesis, introducing the set of monomers still respected as the best available for the vast majority of applications. And, in 1990, we launched what was to become the most comprehensive range of products for the synthesis of the nuclease resistant variant 2'-OMe-RNA.
During 1993, Glen Research announced the Sterling line of products for DNA synthesis based on the highest criteria of quality, purity and reproducibility. Sterling grade is the level to which all other suppliers must aspire and which will lead the way to the development of oligonucleotide therapeutics.
As the market for oligonucleotides, modified and unmodified, continues to grow, Glen Research is committed to continuing to introduce novel reagents and techniques while maintaining our existing product mix and high level of customer service.
上海聚仕隆生物致力于提供科研试剂、耗材、仪器等产品的一站式采购方案
上海聚仕隆生物科技有限公司
:4000867886
:李
:http://www.joslong.cn/
地址:上海市松江区松汇西路1606-2号
世界知名品PaiGlen Research Corp正式授权上海聚仕隆生物科技有限公司为其代理,Glen Research Corp 一直为广大科研客户提供Z为优质的产品和服务;上海聚仕隆自成立以来始终坚持为ZG科研客户带来Z好的产品和体验,Glen Research Corp产品的加入极大地丰富了我们的产品数量和类别,提供更好的一站式采购体验。Glen Research Corp ZG代理,Glen Research Corp上海代理,Glen Research Corp北京代理,Glen Research Corp广东代理,Glen Research Corp天津代理,Glen Research Corp重庆代理,Glen Research Corp江苏代理, Glen Research Corp浙江代理,Glen Research Corp福建代理,Glen Research Corp 浙江代理, Glen Research Corp 黑龙江代理, Glen Research Corp内蒙古代理,Glen Research Corp吉林代理,Glen Research Corp江苏代理, Glen Research Corp 四川代理,Glen Research Corp 广西代理,Glen Research Corp 江西代理,Glen Research Corp陕西代理,Glen Research Corp 山西代理,Glen Research Corp 安徽代理,Glen Research Corp 西安代理,Glen Research Corp武汉代理
本产品信息由(上海聚仕隆生物科技有限公司)为您提供,内容包括(Glen Research Corp 特约代理)的品牌、型号、技术参数、详细介绍等;如果您想了解更多关于(Glen Research Corp 特约代理)的信息,请直接联系供应商,给供应商留言。若当前页面内容侵犯到您的权益,请及时告知我们,我们将马上修改或删除。